Skip to main content
OpenTrials

Clinical trial condition

Unresectable Solid Tumor

Explore clinical trials studying Unresectable Solid Tumor. Study availability and eligibility vary by location and protocol.

16 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Solid Tumor trial results

Recruiting

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NCT07524322

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Houston Houston, Texas, United States
  • NEXT San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

NCT07638371

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +7 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

NCT06244771

Conditions
Advanced Solid Tumors With KRAS G12C Mutations, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations
  • University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center La Jolla, California, United States
  • University of California Irvine (UCI) - Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

NCT06778863

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +51 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • USC - Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 21 locations
View Trial Details
Recruiting

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

NCT05216432

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California-San Diego San Diego, California, United States
  • HealthONE Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 37 locations
View Trial Details
Recruiting

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692

Conditions
Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
Locations
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Providence Saint John's Health Center Santa Monica, California, United States
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
View all 27 locations
View Trial Details

Related conditions